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Summary.-The reproducibility of measurements of oestrogen-receptor activity
has been examined in multiple specimens from a rabbit uterus, a rat mammary
tumour and human breast tumours. The relationship between receptor concentra-
tion and tumour histology has also been investigated in 11 large primary tumours.
In the animal tissues, receptor measurements were relatively reproducible (co-
efficient of variance: wet wt. basis 16-17%, protein basis 16-21°0) but in human
breast tumours receptor activity varied considerably (c.v.: wet wt. basis, 22-125%;
protein basis, 28-7200). In addition to these variations in receptor activity within
tumours, there was a difference between tumours, as demonstrated by an analysis
of variance (P<001).
In the 11 primary breast cancers selected for study, the level of receptor activity was
related to menopausal status and the tumour content of the specimen.
We conclude that the receptor activity detected varies within a tumour and depends
upon the tumour contentofthebiopsyspecimen. Predictions based onprecise quantita-
tion of receptor concentrations may therefore necessitate replicate tumour sampling
and correction for the fraction of non-tumour tissue in each sample.
CURRENTLY, the best index of the
hormonal sensitivity of a breast cancer
is the concentration of oestrogen-receptor
protein in the cytoplasm of the tumour.
(Folca, Glascock and Irvine 1961; Jensen
et al., 1971; McGuire et al., 1975). We have,
therefore, investigated the reproducibility
of receptor measurements and the role of
morphological factors in determiining
variations in receptor concentration.
MATERIALS AND METHODS
Tissues.-To examine the precision of the
receptor assay, multiple (4-8) portions were
cut at 0-40C, from each of 4 tissues selected
for their apparent homogeneity. These tissues
'were the uterus from a non-pregnant rabbit,
a rat mammary carcinoma (generated by the
intragastric administration of 30 mg dimeth-
ylbenz(a)anthracene at 50 days ofage) a large,
cellular, intracanalicular fibroadenoma re-
moved surgically from a 59-year-old woman,
and a lymplh node which had been largely
replaced by anaplastic breast carcinoma from
a 75-year-old woman. Each portion of tissue
was assayed for oestrogen-receptor activity.
To examine the reproducibility of receptor
measurements in human breast cancer an(d
relate this to morphology, 11 mastectomy
specimens containing large, primary breast
cancers were collected on ice. Each tumour
wTas excised from the breast, measured and
sectioned into 2-3 cubes. Each cube was
divided into 2, one portion being used for
histological examination, the other for oestro-
gen-receptor assay.
Oe8trogen-receptor activity was determined
by the method of Hawkins, Hill and Freed-
man (1975). A portion (160 >mg) of fat-free
tumour was homogenized in tris buffer
(0-25 M sucrose, 10 mM tris and 1 mM
ethylene diamine tetra-acetate) at the rate of
100 mg/ml for 3 x 15 s, with intervals for
cooling between periods of homogenization.
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After centrifugation, portions (100 1u) of the
supernatant tumour extract were incubated
with [3H] oestradiol-17fl (10 pg) and varying
concentrations of non-radioactive oestradiol-
17jl (0, 10, 30, 50, 70, 90, 20,000 pg) at 4°C
oveinight. Protein-bound and free oestrogen
were separated by the addition of eharcoal
suspension (0-150/0 w/v) and centrifugation.
The dissociation constant of binding (Kd)
and the concentration of oestrogen-receptor
binding sites (PO fmol/mg wet tumour)
were calculated from a Scatchard (1949)
analysis of the data. The concentration of
oestrogen receptors in each tumour sample
was also expressed on a protein basis (PO,
protein = fmol/mg extracted protein).
Protein concentration in each tumour
extract was determined by the method of
Lowry et al. (1951). Extracts were diluted,
and after reaction with Cu sulphate/Folin-
Ciocalteau Reagent, the optical density at
750 nm was measured and compared with
the values found for standard solutions of
bovine serum albumin (0-100 mg/ml in
water).
Histology.-Tumour specimens were fixed
for 48 h in 100/ buffered formalin (pH 7-0)
processed routinely and embedded in paraffin
wax. Sections 5 ,um thick were stained with
haematoxylin and eosin, and Gomori's alde-
hyde fuchsin.
In addition to the histological structure
and differentiation of each tumour (Scarff
and Torloni, 1968) a semi-quantitative assess-
ment of the tumour content of each specimen
was made by two observers. At the same time,
the elastic tissue content of the tumour wras
assessed. A simple 3-point scale w%-as used to
grade the ratio of tumour: non-tumour
tissue (1 low; 2 moderate; 3 high) and
elastosis (0 not demonstrable, 1 small or
moderate amount and 2 gross amount).
Where there was disagreement between the
two observers, slides were re-read and
classified by agreement.
Statistical analysis-Since the levels of
receptor activity found in breast tumours are
not normally distributed, a logarithmic
function of receptor concentration, loglo
(10 PO + 1) was used for the analysis.
The sources ofdifference in receptor concen-
trations between specimens from the 11
primary tumours were examined by an
analysis ofvariance for nested data (Snedecor
and Cochran, 1971) and assay precision was
calculated as the coefficient of variation from
duplicate determinations (Snedecor, 1952).
Mean oestrogen-receptor concentration was
assessed primarily in relation to tumour
content by the Rank Correlation Test
(Kendall, 1975). No attempt was made to
study partial rank correlations for which
adequate significance tests have not been
devised.
RESULTS
Apparently homogeneous tissues
The precisioni of measurements of
receptor concentration (PO) in two super-
ficially homogeneous animal tissues (uterus
and mammary carcinoma) was 16-1700
on a wet-wt basis (Table I). The mean
TABLE I.-Precision of Oestrogen-receptor Determinations in a Rat
and Rabbit Uterus
Rat mammaiy tumour
fmol/mg fmol/mg
Specimen wet wt protein
A
B
C
D
E
F
2-1
1-8
2-2
1 -8
1-5
1 6
Mean 1-8
s.d. 0-29
Precision 160%
20
16
19
14
12
13
Mammary Tumour
Rabbit uterus
fmol/mg fmol/mg
Specimen wet wt protein
A
B
C
D
E
F
G
H
26-5
19-9
20-6
18-4
21-6
26-8
21-0
16-5
15-6 Mean 21-4
3-3 s.d. 3-6
21 % Precisioin 170%
316
240
252
225
279
322
264
201
262
43
16%
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TABLE II. Precision of Oestrogen-receptor Determination in a Secondary Breast Cancer
and a Giant Fibroadenoma
Invadle(1 lymph node
fmol/mg fm-iol/mg
Specimen wvet wt protein
A
B
C
D
E
:386
48-0
44 1
47-8
121 .0*
Meain 5909
s.d. 43.4
Precisioll 580%
386
540
865
774
1445*
802
406
51 %
Giant fibroadenoma
fmol/mg
Specimen wet wt I
A
B
D
Mean
S.d.
Precision
8-5
5-8
1 9
2 6
4-7
30
65%
* Over,estimate since saturation barely achieved with 100 pg inonradioactive
oestradiol-17j3, leading to high apparent Kd=2-5x 10-10 molar (cf. 0 68-lOx
0-1 0 molar for the other specimens A-D).
value forthe dissociation constant (Kd) was
0 33 x 10-10 molar for rabbit uterus and
0*39x 10-10 molar for rat mammary
carcinoma, measured with coefficients of
variation of 21% and 33%o respectively.
In contrast to these animal tissues, the
precision of the measurements in human
tumours was rather low, being 650o in
the giant fibroadenoma and 58% in the
secondary breast cancer, on a wet-wt
basis (Table II). The mean (lissociation
constants in these tissues were 0-37x
10-10 molar with a precision of 9.2% in
the fibroadenoma and I1 7 x 10-10 molar
TABLE II1. Oestrogen-receptor Activity
(fmol/mg twet wt) in 2-3 Portions from
Primary Breast Cancer
Patient Specimen A Specimeni B Specimeni C
Premenopausal an(d menopauisal
.JB
GS
MO
HC
DB
EG
0-29
0-26
0 52
1 12
1.51
Postmeniopausal
RP 3.53
SD 3 50
AP 5-15
MP 11-7
HL 29-4
0
0*55
0 65
0-41
1.35
2-54
2-42
1 07
2-38
16 9
29 4
0-26
1 76
1 69
2 394
77*2*
* Overestimate siince saturation barely achieved
Nwrith 100 pg noniadioactive oestraadiol-17l, leading
to Kd of 0 45x 10-10 molar (c.f. 0-11 and 015x
10-10 molar for other specimens from same tisstue).
with a precision of 490o in the secondary
cancer, the latter value including an
abnormally high value (2.5 x 10-10 molar
for Specimen E, Table 11).
Expression of these results on a protein
basis (Tables I and II) did not correct for
the apparent variation in receptor levels
between specimens from the same tumour.
Primary breast cancers
The results of oestrogen-receptor assays
in multiple specimens from the 11 primary
breast cancers are given in Table III, in
which tumours have been subdivided
according to the menstrual status of the
patient. Mean receptor concentrations
were significantly higher in the post-
menopausal group (e.g. Table VI). The
dissociation constants for all the speci-
mens were in the range of0 11-0 99 x 10-10
molar and averaged 0 52+0 24x ]0-10
molar for premenopausal and 0 40±0 19
x 1o-10 for postmenopausal women.
In an analysis of variance (Table IV),
after elimination ofthis effect ofmenstrual
status, significant differences in receptor
activity, which would not be accounted
for by intra-tumour variation, were shown
to exist between tumours (P<0 01). More-
over, within a single tumour, receptor
concentrations may vary up to 7-fold.
Using two results for each tumour from
Table II as duplicate determinations, the
fmol/mg
protein
167
116
26
49
89-5
64-2
72%
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TABLE IV.--Analysis of Variance of Oestrogen-receptor Concentrations in 11 Primary
Breast Cancers*
Souirce of variation
Groups (pre- andl post-
meniopausal)
Bet,ween tuimouirs (xN ithin a
group
WVithini turlnourls (residual)
Total
Degiees of Sum of Mean
freedom squares squares
7 06
9
16 5.44
0 73
7-06
S2
0 46
0*60j 0 23
0 045t 0(045
26 13 23
* Anialysis was perfoime(d oni the wet weight-based data, after linear followed by
logarithmic tranisformation.
t F9, 16 ratio, -60 10-3; thus the dlifference between tumours is significantly 0-045
gr-eater than that wvhich cani be accounted for by within-tumour variation, P<0-01.
coefficienit of variation was 220o (dupli-
cates selected by randomization) or 41%
(usiing the two most divergent values as
duplicates) for the premenopausal group
and 1250° (randomized or most divergent
duplicates) for the postmenopausal group.
These variations were at mean concentra-
tions of -09 and 165 fmol/mg wet wt.,
respectively.
Expression of results on a protein basis
did not influence its variation (Table V).
On this basis, the calculated coefficients of
variation between duplicates were 2800
(ran(lom duplicates) or 54%o (most diver-
gent values) for primaries from premeno-
pausal patients, and 580o (random duplic-
ates) or 59°, (most divergent values) for
TABLE V. Oestrogen-receptor Activity
(fmol/mg protein) in 2-3 Portions from
Primary Breacst Cancers
Patient Specimen A Specimen B Specimeni C
1Premnenopausal andi( menopausal
J 13 0 0
GS 9 14
MO 6 17
HC 10 8
DB3 22 23
EG 35 69
P'ostmenopaul,asal
HP 91
SD 125
Al' 184
MP 245
HL 1089
90
31
68
184
1547
7
48
55
95
889*
* Overeestiumate. See footnote to Table III.
primaries from postmenopausal patients
(Table V).
Relationship between oestrogen-receptor
activity and tumour morphology
The morphological characteristics ofthe
11 primary breast cancers and the mean
receptor activity for each tumour are
listed in Table VI. All 11 tumours exam-
ined were classified as infiltrative ductal
carcinomas.
100-t
oestrogen
receptor
concn.
(fmot / mg
10-
1-
0
0
0
0
0 a
a
I
0
0
0
0
OD
0
3
tumour content
Fitct. Oestrogen-receptor concentration aind
tumour content in 27 specimens from 11
primary breast cancers: receptoi activity
(wet, wt basis) for each specimen is plotted
against, the proportion of tumour: non-
tumour tissue found upon histological
examination of the adjacent, area of the
cancer. 0, premenopausal/menopausal
patients; 0, postmenopausal patients.
-j.
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IOESTROGEN-RECEPTOR IN BREAST CANCER
TABLE VI.-Oestrogen-receptor Concentration and Morphology in 11
Cancers
Patient
Tumour
size
(cm)
Premenopausal and menopausal
JB 3
HC 6
GS 3-5
MO 5
DB 3
EG 4
Postmenopausal
SD
RP
AP
HL
MS'
7
4-5
3
4
4
Histological
characterl
II
II
II
II
II
II
II
II
III
II
II
Tumour
content*t
1
2
2
1
2
2-3
1*5
2-3
2-7
2-5
2-7
Primary Breast
Receptor
concentrationt
Elastosist (fmol/mg wet wt)
0.5
1
1
1
1*5
0 3
1
1
0 7
1*5
1
0
0 40
0-42
0*45
1*23
1 94
2-28
2-55
3.49
29-4
35-3
* Grade significantly correlated with mean receptor level (P<0-02).
t Value shown is mean of the values found for the individual specimens. Tumour: non-tumour tissue
ratio: 1 = low, 2 = moderate, 3 = high. Elastosis grading: 0 = none, 1 = small or moderate, 2 =
gross amount.
I Infiltrative ductal carcinoma of grade shown.
Using the Rank Correlation Test, a
significant, positive correlation (P<0.02)
was found between mean tumour content
and the mean receptor activity for the
same tumour. This is illustrated in the
Figure, which shows the individual result
for each of the 27 specimens taken from
the 11 primary tumours, though the Rank
Correlation Test was performed on the
11 mean values (Table VI).
DISCUSSION
It is generally held that biological
assays for clinical use should have a
precision (coefficient ofvariation) ofbetter
than 15% (Whitby, Mitchell and Moss,
1967). We found that the precision of the
measurement of oestrogen-receptor con-
centrations in two relatively homogeneous
tissues obtained from animals was 16-170%
(wet wt basis). This compares well with
the 16% reported by Braunsberg (1975)
who used human tumours which, to
ensure homogeneity, were each minced
and mixed before assay in duplicate.
When human tumours (a secondary
breast cancer, a giant fibroadenoma and
11 primary breast cancers) were examined,
24
the precision of the measurement of
receptor concentrations fell to 22-125%
(wet wt basis) and that of dissociation
constant to 46-47%. Although this degree
ofimprecision is exaggerated for two ofthe
36 specimens studied (see footnotes to
Tables II and III) which had highreceptor
concentrations barely saturable at the
levels of oestrogen used in the assay
(100 pg), considerable differences in recep-
tor activity were observed between ad-
jacent specimens in 11/13 tumours. This
finding is in agreement with the earlier
reports of Braunsberg (1975) and of
Leclereq et al., (1975).
Expression ofthereceptor concentration
on a protein basis did not improve the
precision of measurements, findings in
agreement with those of Rosen et al.
(1975) and Jensen et al. (1975). However,
the methods used for preparing tumour
extracts differed from those of Leclereq
et al. (1973) and of Teulings et al. (1975),
who did find a relationship between
receptor and protein concentrations.
Although the 11 primary breast cancers
studied represent a small and pathological-
ly atypical series, a significant correlation
was found between receptor activity and
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amount of tumour present in the specimen
studied. This relationship, which we have
now confirmed in a large number of
tumours (Masters et al., to be published)
has not been reported previously (McGuire
et al., 1 975). A similar trend, however, can
be seen in the relationship betweeni
cellularity and receptor concentration in
a study of 333 breast lesions by Rosen
et al. (1975), who noted that receptor
concentration was significantly related
also to histological type of tumour.
Two important observations emerge
from this work. Firstly, we conclude that
the quantitation of oestrogen-receptor
activity based on a single sample of a
tumour is imprecise, and that if critical
levels of receptor activity are to be used
to select patients for treatment by endo-
crine means, such assays are oflittle value.
Secondly, we have presented evidence that
the variation in receptor activity between
tumours is partly due to variations in
tumour content. The use of receptor
measurements for predicting response
must, therefore, be considered in con-
junction with some assessment of the
proportion of tumour present in the
biopsy specimen assayed.
In addition to the two deficiencies
reported above, two further limitations
apply to most of the methods currently
employed in this and other laboratories
for the estimation of oestrogen-receptor
activity: in general, assays (i) only
measure available (empty) receptor sites,
and (ii) are susceptible to interference by
plasma components (Hawkins, Scott and
Yap, 1977). Until oestrogen-receptor
methodology is iniproved to take all these
4 deficiencies into account, with some
standardization of assay conditions such
as sensitivity, correction for non-specific
binding and quality-control, the relation-
ship between tumour receptor concentra-
tion and response to endocrine therapy
cannot be clearly established.
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